...
首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Optimization of perfusate pH to improve microdialysis recovery of lipophilic compounds
【24h】

Optimization of perfusate pH to improve microdialysis recovery of lipophilic compounds

机译:优化灌注液pH以改善亲脂性化合物的微透析回收率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction: Microdialysis (MD) allows sampling of compounds in-vivo from tissues' interstitial fluid. However, molecules insoluble at physiological pH have usually extremely low recovery. The addition of albumin to the perfusate or the use of isotonic lipoemulsion improves recovery of these molecules although it requires a cleaning step before HPLC analysis. This study investigates the possibility of improving the MD recovery of compounds insoluble at physiological pH but soluble at a different pH. The probe is perfused with an isotonic solution adjusted to pH values at which the compound has maximum solubility. Ketoconazole (KTC), clotrimazole (CLT) and tretinoin (TTN) were selected as model drugs because they are almost insoluble at pH 7.4 but soluble at pH 4 for KTC and CTL; and at pH 9 for TTN. Methods: Linear microdialysis probes were used to collect KTC, CLT or TTN from a standard solution of the compounds. Probes were perfused with 0.01 M pH 7.4 isotonic buffer solution (1) without or (2) with 5% Bovine Serum Albumin (BSA); or (3) with 20% isotonic lipoemulsion; or (4) with 0.01 M pH 4 isotonic buffer solution for KTC and CLT or 0.01 M pH 9 isotonic buffer solution for TTN. The method was then tested in-vivo, in rabbit skin, to assess the skin tolerance to the non-physiological perfusates and to monitor KTC and TTN delivery from commercial cream products. Results: In-vitro, the optimized-pH perfusate increased MD recovery significantly (P<0.001): 6.9 (KTC), 8.3 (CLT), and 2.0 (TTN) times compared to the physiological pH and 1.4 and 1.2 compared to the BSA and lipoemulsion respectively. No evidence of irritation or edema was observed in-vivo. However, KTC and TTN were not detected in-vivo with any of the modified perfusate tested. Discussion: These findings show that the optimized-pH perfusate effectively increases the in-vitro microdialysis recovery of KTC, CLT and TTN and that it is well tolerated in-vivo. However, the compounds tested (KTC and TTN) could not be detected in-vivo.
机译:简介:微透析(MD)允许从组织的组织液中进行体内化合物采样。然而,在生理pH下不溶的分子通常具有极低的回收率。向灌注液中添加白蛋白或使用等渗脂肪乳剂可改善这些分子的回收率,尽管这需要在HPLC分析之前进行清洁。这项研究探讨了改善在生理pH下不溶但在不同pH下可溶的化合物的MD回收率的可能性。用等渗溶液灌注探针,等渗溶液的pH值调节至化合物具有最大溶解度。选择酮康唑(KTC),克霉唑(CLT)和维甲酸(TTN)作为模型药物,因为它们对于KTC和CTL在pH 7.4时几乎不溶,但在pH 4时可溶。对于TTN,pH为9。方法:使用线性微透析探针从化合物的标准溶液中收集KTC,CLT或TTN。用0.01 M pH 7.4等渗缓冲溶液(1)不使用或(2)用5%牛血清白蛋白(BSA)灌注探针; (3)等渗脂肪乳剂含量为20%;或或(4)使用KTC和CLT的0.01 M pH 4等渗缓冲溶液或TTN的0.01 M pH 9等渗缓冲溶液。然后对该方法在兔皮肤中进行体内测试,以评估其对非生理灌洗液的耐受性,并监测商品乳膏产品中的KTC和TTN递送情况。结果:在体外,优化pH灌注液可显着提高MD回收率(P <0.001):与生理pH相比,分别为6.9(KTC),8.3(CLT)和2.0(TTN)倍,与BSA相比,分别为1.4和1.2和脂肪乳剂。体内未见刺激或水肿的迹象。但是,在测试的任何改性灌注液中均未在体内检测到KTC和TTN。讨论:这些发现表明,优化的pH灌注液可有效提高KTC,CLT和TTN的体外微透析回收率,并且体内耐受性良好。但是,无法在体内检测到所测试的化合物(KTC和TTN)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号